Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.

Gando S, Saitoh D, Ishikura H, Ueyama M, Otomo Y, Oda S, Kushimoto S, Tanjoh K, Mayumi T, Ikeda T, Iba T, Eguchi Y, Okamoto K, Ogura H, Koseki K, Sakamoto Y, Takayama Y, Shirai K, Takasu O, Inoue Y, Mashiko K, Tsubota T, Endo S; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group for the JAAM DIC Antithrombin Trial (JAAMDICAT).

Crit Care. 2013 Dec 16;17(6):R297. doi: 10.1186/cc13163.

2.

Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.

Sawamura A, Gando S, Hayakawa M, Hoshino H, Kubota N, Sugano M.

Clin Appl Thromb Hemost. 2009 Oct;15(5):561-6. doi: 10.1177/1076029608323497. Epub 2008 Oct 7.

PMID:
18840625
3.

The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.

Iba T, Saitoh D, Gando S, Thachil J.

Thromb Res. 2015 May;135(5):897-901. doi: 10.1016/j.thromres.2015.03.007. Epub 2015 Mar 10.

PMID:
25784136
4.

Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.

Nishiyama T, Kohno Y, Koishi K.

Am J Emerg Med. 2012 Sep;30(7):1219-23. doi: 10.1016/j.ajem.2011.06.003. Epub 2011 Dec 26.

PMID:
22204993
5.

A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.

Wiedermann CJ, Kaneider NC.

Blood Coagul Fibrinolysis. 2006 Oct;17(7):521-6. Review.

PMID:
16988545
6.

A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.

Takazono T, Nakamura S, Imamura Y, Yoshioka S, Miyazaki T, Izumikawa K, Sawai T, Matsuo N, Yanagihara K, Suyama N, Kohno S.

J Infect Chemother. 2014 Aug;20(8):484-8. doi: 10.1016/j.jiac.2014.04.010. Epub 2014 May 21.

PMID:
24855912
7.

Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.

Iba T, Gando S, Saitoh D, Wada H, Di Nisio M, Thachil J.

Thromb Res. 2016 Sep;145:46-50. doi: 10.1016/j.thromres.2016.07.016. Epub 2016 Jul 27.

PMID:
27479532
8.

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.

Iba T, Saitoh D, Wada H, Asakura H.

Crit Care. 2014 Sep 15;18(5):497. doi: 10.1186/s13054-014-0497-x.

9.

Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Iba T, Thachil J.

Int J Hematol. 2016 Mar;103(3):253-61. doi: 10.1007/s12185-015-1904-z. Epub 2015 Nov 20. Review.

PMID:
26588929
10.

Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.

Kushimoto S, Gando S, Saitoh D, Ogura H, Mayumi T, Koseki K, Ikeda T, Ishikura H, Iba T, Ueyama M, Eguchi Y, Otomo Y, Okamoto K, Endo S, Shimazaki S; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group.

Thromb Haemost. 2008 Dec;100(6):1099-105.

PMID:
19132236
11.

A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.

Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group.

Crit Care Med. 2006 Mar;34(3):625-31.

PMID:
16521260
12.

A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis.

Gando S, Saitoh D, Ogura H, Fujishima S, Mayumi T, Araki T, Ikeda H, Kotani J, Kushimoto S, Miki Y, Shiraishi S, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, Aikawa N; Japanese Association for Acute Medicine Sepsis Registry Study Group.

Crit Care. 2013 Jun 20;17(3):R111. doi: 10.1186/cc12783.

13.

Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?

Nishiyama T, Matsukawa T, Hanaoka K.

Crit Care Med. 2000 May;28(5):1419-22.

PMID:
10834689
14.

Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.

Kawano S, Uchino S, Endo A, Saito K, Iwai K, Kase Y, Takinami M.

Blood Coagul Fibrinolysis. 2014 Dec;25(8):795-800. doi: 10.1097/MBC.0000000000000115.

PMID:
24806318
15.

Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.

Gando S, Kameue T, Nanzaki S, Nakanishi Y.

Thromb Haemost. 1996 Feb;75(2):224-8.

PMID:
8815564
16.

The efficacy of antithrombin administration in the acute phase of burn injury.

Lavrentieva A, Kontakiotis T, Bitzani M, Parlapani A, Thomareis O, Scourtis H, Tsotsolis N, Lazaridis L, Giala MA.

Thromb Haemost. 2008 Aug;100(2):286-90.

PMID:
18690349
17.

Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.

Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H.

J Thromb Haemost. 2014 Sep;12(9):1470-9. doi: 10.1111/jth.12643. Epub 2014 Jul 16. Erratum in: J Thromb Haemost. 2015 Jan;13(1):165.

19.
20.

Studies on therapeutic effects and pathological features of an antithrombin preparation in septic disseminated intravascular coagulation patients.

Sakamoto Y, Inoue S, Iwamura T, Yamashita T, Nakashima A, Nishimura Y, Koami H, Imahase H, Goto A, Yamada KC, Mashiko K, Yokota H.

Yonsei Med J. 2013 May 1;54(3):686-9. doi: 10.3349/ymj.2013.54.3.686.

Supplemental Content

Support Center